ArticleVaccines2022

A Novel Therapeutic Tumor Vaccine Targeting MUC1 in Combination with PD-L1 Elicits Specific Anti-Tumor Immunity in Mice.

Jiayi Pan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.